The Supreme Court closed the IMA’s case against Patanjali over misleading ads and lifted its stay on the Centre’s deletion of Rule 170. AYUSH medicine ads can now run without prior State licensing approval.
Kerala: Today, 6th Feb, Baba Ramdev and Acharya Balkrishna, the promoters of Patanjali Ayurved, have filed an application in a Kerala court, requesting the recall of a non-bailable arrest warrant that was issued against them for not attending a scheduled court hearing in a case related to misleading advertisements.
A Palakkad court issued a non-bailable warrant against Baba Ramdev in a case filed by the Drugs Inspector. The case, registered in October 2024, falls under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. It alleges violations related to misleading medical claims. The court’s order highlights legal action against unverified health advertisements.
A Kerala court has issued a bailable arrest warrant against Baba Ramdev and Acharya Balakrishna after allegations of misleading claims about Patanjali Ayurved products curing ailments like diabetes and high blood pressure. The case, triggered by complaints from ophthalmologist K.V. Babu, cites violations of the Drugs and Magic Remedies Act. This action follows the Supreme Court’s warning against unchecked misleading advertisements.
Patanjali Ayurved co-founders, Baba Ramdev and Acharya Balkrishna, are facing criminal proceedings for deceptive advertising. The case centers on purportedly misleading advertisements, leading to contempt of court proceedings. The charges, rooted in the Drugs And Magic Remedies Act, reflect the government’s resolve to uphold advertising integrity. The outcome could impact advertising regulations.
An official from Patanjali and two others sentenced to six months in jail after their Soan Papdi product failed a quality test. The District Food Safety Officer collected samples following concerns, leading to legal action. The court imposed fines on the individuals and the company. This incident highlights food safety and regulatory compliance issues in the industry.
![[Patanjali Fake Ads Case] SC Reserves Verdict in Contempt Of Court Against Patanjali](https://i0.wp.com/lawchakra.in/wp-content/uploads/2024/04/patanjali1.jpg?resize=447%2C367&ssl=1)
Today (14th May): The Supreme Court of India reserved its verdict in the contempt of court case against Patanjali Ayurved and its owners, Baba Ramdev and Acharya Balkrishna, over misleading advertisements. The court dispensed with their personal appearance pending the submission of an affidavit detailing the steps taken to remove the misleading ads and recall suspended products. The case has drawn attention to larger issues, including unethical practices in modern medicine and the liability of celebrities endorsing misleading advertisements.
The Managing Director of Patanjali Ayurveda, Acharya Balkrishna, filed a plea against the President of the Indian Medical Association (IMA), Dr. RV Asokan, for disparaging remarks about the Supreme Court. This arises from the Court’s criticism of IMA’s unethical practices. Simultaneously, the Supreme Court is hearing a petition by IMA against Patanjali Ayurveda for misleading advertisements.